New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
07:36 EDTAPRIApricus Biosciences announces multi-year partnership with SRF
Apricus Biosciences announced a multi-year partnership agreement with the Scleroderma Research Foundation, or SRF, to support the foundation's activities and the further progress of SRF's groundbreaking research programs. As part of the partnership, Apricus will co-sponsor an upcoming Scleroderma Research Roundtable Series and plans to participate in SRF's Annual Scientific Workshop and an SRF-sponsored event to take place at the upcoming American College of Rheumatology 2014 Annual Meeting. Apricus' product candidate for the treatment of Raynaud's phenomenon, RayVa, is expected to begin a phase 2a clinical trial in the second half of 2014.
News For APRI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
07:35 EDTAPRIApricus Biosciences appoints Barbara Troupin, M.D. as Chief Medical Officer
Subscribe for More Information
December 8, 2014
16:03 EDTAPRIApricus Biosciences files to sell 3.42M share for selling stock holder
Subscribe for More Information
December 4, 2014
07:40 EDTAPRIApricus announces first patient enrolled in RayVa Phase 2a clinical trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use